Business StandardCenter·
Sun Pharma bags rights to $3.7 billion cholesterol drug market globally
Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after its EU approval
Read at Business Standard →



